PharVision Advisers’s Fluence Energy FLNC Stock Holding History

PharVision Advisers’s Portfolio FLNC Stock Details FLNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-34,897	Closed	-$377K	–	788
2025 Q3	$377K	Buy	+34,897	New	+$292K	0.21%	102

Other funds holding FLNC

SPT

Siemens Pension Trust Munich Germany, Germany $437M AUM 183.71% 1-Year Est. Return

Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PharVision Advisers's FLNC Position: Q4 2025 in Review

PharVision Advisers sold out of Fluence Energy (FLNC) in Q4 2025, closing a stake of 34,897 shares — an estimated $377K sold.

PharVision Advisers first reported a position in FLNC in Q3 2025 and held it in 1 quarter. The position peaked at $377K in Q3 2025. 260 funds tracked by Wall St. Rank hold FLNC as of Q4 2025.

PharVision Advisers reported no remaining Fluence Energy position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 34,897 Fluence Energy shares in Q4 2025, an estimated $377K.
PharVision Advisers first reported a position in Fluence Energy in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Fluence Energy position peaked at $377K in Q3 2025.
260 funds tracked by Wall St. Rank held Fluence Energy as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.